The Ansar Group, Inc. - Home Page

Our Mission Statement

ANSAR is the innovator of noninvasive real-time digital autonomic nervous system monitoring.

An MIT patent, to which ANSAR holds the exclusive license, establishes the constants for our heart rate variability methodology - the frequency method using spectral analysis, the only HRV method to quantify both branches (sympathetic and parasympathetic), of the autonomic nervous system.

Ansar is committed to excellence in patient care and to improving the safety, efficiency, and cost-effectiveness of health care technology.

Ansar's patented ANX 3.0 Autonomic Nervous System monitoring technology:

  • Measures both branches of the Autonomic Nervous     System (the sympathetic and the parasympathetic)     independently and simultaneously in real-time.

  • Has 2 reimbursable CPT codes for Autonomic     Nervous System testing.

  • Has FDA 510(k) Market Clearance.

  • Have you seen our ad in the journal or publication that serves your specialty?

    Are you interested in learning more about CAN (Cardiovascular Autonomic Neuropathy) and how Ansar's technology can detect autonomic degradation which can lead to PAN, DAN, and ultimately CAN?

    For more information please click here

    About Us | Help | Privacy Policy | Contact Us | ©2005 The Ansar Group, Inc.